We are live on
!
Find out more
NAP
New Amsterdam Partners Portfolio holdings
AUM
$272M
Turnover
40.71%
1-Year Est. Return
12.21%
This Fund
S&P 500
This Quarter
Est. Return
-0.89%
1 Year Est. Return
+12.21%
3 Year Est. Return
+73.94%
5 Year Est. Return
+120.95%
10 Year Est. Return
–
AUM
$458M
AUM Growth
-$42.3M
(-8.5%)
Cap. Flow
-$29.1M
Cap. Flow
% of AUM
-6.35%
Top 10 Holdings %
Top 10 Hldgs %
25.63%
Holding
140
New
27
Increased
15
Reduced
71
Closed
27
Avg Time Held
1.1
years
Top 10 Avg Time Held
0.6
years
Top 20 Avg Time Held
0.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMN Healthcare
AMN
|
+$6.02M |
| 2 |
Federated Hermes
FHI
|
+$5.71M |
| 3 |
EXL Service
EXLS
|
+$5.54M |
| 4 |
MKS Inc
MKSI
|
+$5.54M |
| 5 |
USCR
U S Concrete, Inc.
USCR
|
+$3.66M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Innospec
IOSP
|
+$12.6M |
| 2 |
OAK
OAKTREE CAPITAL GROUP, LLC
OAK
|
+$5.76M |
| 3 |
DST
DST Systems Inc.
DST
|
+$5.42M |
| 4 |
LPNT
LifePoint Health, Inc.
LPNT
|
+$4.87M |
| 5 |
NTRI
NutriSystem, Inc.
NTRI
|
+$4.33M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.22% |
| 2 | Industrials | 19.04% |
| 3 | Consumer Discretionary | 15.72% |
| 4 | Financials | 13.25% |
| 5 | Healthcare | 10.19% |
Similar funds
TAT
SAS
BA
TRIM
CFS
SVWA
LYV
TCM
New Amsterdam Partners's Q1 2018 Portfolio in Review
As of Q1 2018, New Amsterdam Partners held 140 positions worth $458M, down 8.5% from $500M the previous quarter. Its ten largest holdings account for 26% of the portfolio.
New Amsterdam Partners withdrew a net $29.1M in Q1 2018, closing 27 positions and reducing 71 holdings. Its most notable exit was Innospec, an estimated $12.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, New Amsterdam Partners opened a new position in AMN Healthcare worth $6.29M.
- New Amsterdam Partners's largest Q1 2018 buy was AMN Healthcare: 110,820 shares worth $6.29M.
- New Amsterdam Partners added most to Regal Rexnord in Q1 2018, an estimated $3.49M increase.
- New Amsterdam Partners's biggest Q1 2018 reduction was NutriSystem, Inc., cutting an estimated $4.33M.
- New Amsterdam Partners fully exited Innospec in Q1 2018, selling an estimated $12.6M.
- New Amsterdam Partners's ten largest holdings make up 26% of its $458M portfolio in Q1 2018.
- New Amsterdam Partners opened 27 new positions and closed 27 in Q1 2018.
- New Amsterdam Partners's portfolio value fell 8.5% quarter-over-quarter to $458M.
Based on New Amsterdam Partners's 13F filing for Q1 2018, filed 7 May 2018.